The impact of intestinal absorption of P on serum P levels is critical at the time CKD has progressed to stages 4–5 when the kidney filtration of P is very limited and the ability to excrete P in the urine is markedly impaired despite the phosphaturic stimulus of FGF23 and PTH. This evidence concerns the gene FGF23 and chronic kidney disease.